NYSE: AIM - AIM ImmunoTech Inc.

छह महीने के लिए लाभप्रदता: -50.01%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम AIM ImmunoTech Inc.


कंपनी के बारे में AIM ImmunoTech Inc.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS).

अधिक जानकारी
It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; Pharmaceutics International Inc.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

IPO date 1996-07-12
ISIN US00901B1052
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://aimimmuno.com
Цена ао 0.2969
प्रति दिन मूल्य परिवर्तन: -3.92% (0.255)
प्रति सप्ताह मूल्य परिवर्तन: +0.823% (0.243)
प्रति माह मूल्य परिवर्तन: -29.6% (0.348)
3 महीने में कीमत में बदलाव: -32.02% (0.3604)
छह महीने में कीमत में बदलाव: -50.01% (0.4901)
प्रति वर्ष मूल्य परिवर्तन: -57.02% (0.57)
3 वर्षों में मूल्य परिवर्तन: -87.63% (1.98)
5 वर्षों में मूल्य परिवर्तन: -90.65% (2.62)
10 वर्षों में मूल्य परिवर्तन: 0% (0.245)
वर्ष की शुरुआत से मूल्य परिवर्तन: -34.84% (0.376)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
कुल: 2.5

क्षमता

नाम अर्थ श्रेणी
ROA, % 0 0
ROE, % 0 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA 0 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -61.58 0
लाभप्रदता Ebitda, % 70.45 8
लाभप्रदता EPS, % -92.56 0
कुल: 5

संस्थानों आयतन शेयर करना, %
Vanguard Group Inc 1988704 3.99
Blackrock Inc. 707806 1.42
Geode Capital Management, LLC 351657 0.7
Renaissance Technologies, LLC 202008 0.4
State Street Corporation 173103 0.35
Verition Fund Management, LLC 162000 0.32
Bridgeway Capital Management, Inc. 108900 0.22
Northern Trust Corporation 85566 0.17
Morgan Stanley 77318 0.15
Seacrest Wealth Management, LLC 37063 0.07

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
SPDR S&P International Small Cap ETF 0.02113 8.94 3.10348
Dimensional International Small Cap Value ETF 0.00214 7.13 4.55441
SPDR Portfolio Developed World ex-US ETF 0.00183 5.29 3.28401
Avantis Responsible International Equity ETF 0.00127 17.44 3.61591
Dimensional International Small Cap ETF 0.00079 5.69 3.34747
Avantis International Equity ETF 0.0002 6.46 3.80856



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Thomas K. Equels Esq., J.D., M.S. Executive Vice Chairman, CEO & President 953.19k 1953 (72 वर्ष)
Mr. Robert Dickey IV, M.B.A. Chief Financial Officer 64.48k 1956 (69 साल)
Mr. Peter W. Rodino III, Esq., J.D. COO, Executive Director of Governmental Relations, General Counsel & Secretary 484.94k 1951 (74 वर्ष)
Ann Marie E. Coverly Director of Administration & Human Resources and Deputy Investor Relations Coordinator N/A
Dr. Christopher McAleer Ph.D. Scientific Officer N/A
Dr. Ralph Christopher Cavalli Ph.D. Vice President of QC & Manufacturing 234.79k 1958 (67 साल)

पता: United States, Ocala. FL, 2117 SW Highway 484 - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://aimimmuno.com